Paxlovid didn’t shorten Covid symptoms in vaccinated adults, full trial results confirm – Endpoints News April 4, 2024
Bristol Myers and 2seventy bio say FDA delayed CAR-T therapy decision – Endpoints News November 20, 2023
FDA approves Junshi, Coherus’ PD-1 toripalimab for nasopharyngeal carcinoma – Endpoints News October 30, 2023
Sanofi’s atopic dermatitis drug amlitelimab hits primary endpoint, on its way to PhIII trial – Endpoints News October 13, 2023
Novo Nordisk snaps up Inversago Pharma for up to $1B+ on the back of megablockbuster Wegovy sales – Endpoints News August 10, 2023
Sage suggests job and pipeline cuts after FDA rejection of major depression pill – Endpoints News August 7, 2023
Updated: EQRx sells itself to another Alexis Borisy company, Revolution Medicines, in all-stock deal – Endpoints News August 1, 2023
AstraZeneca dives into regulatory T cell therapies in deal with Quell Therapeutics – Endpoints News June 9, 2023
Moderna, Merck say their cancer vaccine reduces metastases by 65% in PhII study of high-risk melanoma: #ASCO23 – Endpoints News June 5, 2023